Company Filing History:
Years Active: 2018
Title: TaegSu Jang: Innovator in Pharmaceutical Chemistry
Introduction
TaegSu Jang is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. His work focuses on addressing metabolic disorders, including diabetes mellitus.
Latest Patents
TaegSu Jang holds a patent for "Piperidine derivatives for GPR119 agonist." This invention relates to novel piperidine derivatives, their stereoisomers, and pharmaceutically acceptable salts. The patent outlines methods for preparing these compounds and pharmaceutical compositions that include them. The piperidine derivatives developed by Jang have shown potential as GPR119 agonists, which can be utilized in the treatment of metabolic disorders, especially type II diabetes and related conditions.
Career Highlights
TaegSu Jang is associated with Chong Kun Dang Pharmaceutical Corporation, where he applies his expertise in pharmaceutical research and development. His innovative approach has led to advancements in drug formulation and therapeutic applications.
Collaborations
He has collaborated with notable colleagues, including ChangSik Lee and Daekyu Choi, to further enhance the research and development efforts within the company.
Conclusion
TaegSu Jang's contributions to pharmaceutical chemistry, particularly through his patent on piperidine derivatives, highlight his role as an innovator in the field. His work continues to impact the treatment of metabolic disorders, showcasing the importance of innovation in healthcare.